[Should we screen and treat subclinical hypothyroidism?]

Virgini, Vanessa; Collet, Tinh-Hai; Christ, Emanuel; Aujesky, Drahomir; Rodondi, Nicolas (2012). [Should we screen and treat subclinical hypothyroidism?]. Revue médicale suisse, 8(331), 501-2, 504-6. Genève: Médecine & Hygiène

Full text not available from this repository. (Request a copy)

Subclinical hypothyroidism, defined as an elevated thyroid stimulating hormone and normal thyroxine level, is common with aging, particularly after 65 years old. This condition is potentially associated with important consequences, such as cardiovascular diseases and cognitive disorders. So far, indications for screening and thyroxine replacement therapy are still controversial. In this review, we examine the data on those risks and the potential benefits of the treatment. We also present a large European randomized clinical trial that should clarify this controversy, in order to improve clinical care of patients with subclinical hypothyroidism and to give reliable data on maintaining good health among the elderly.

Item Type:

Journal Article (Further Contribution)


04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine

UniBE Contributor:

Christ, Emanuel and Aujesky, Drahomir




Médecine & Hygiène




Factscience Import

Date Deposited:

04 Oct 2013 14:26

Last Modified:

17 Mar 2015 21:08

PubMed ID:



https://boris.unibe.ch/id/eprint/9378 (FactScience: 215108)

Actions (login required)

Edit item Edit item
Provide Feedback